ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Gemcitabine and Abraxane to Treat Potentially Operable Pancreatic Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01298011
Recruitment Status : Completed
First Posted : February 17, 2011
Last Update Posted : June 17, 2015
Sponsor:
Collaborator:
Celgene Corporation
Information provided by (Responsible Party):
Pancreatic Cancer Research Team

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 2013
  Actual Study Completion Date : May 2015